Interview with Interview with Dr. Beatrice Aramini from The University of Modena and Reggio Emilia

Name: Interview with Interview with Dr. Beatrice Aramini from The University of Modena and Reggio Emilia
Uploaded: 2020-11-02
Duration: 6 min 54 s
Description: Interview regarding their article published in Oncotarget Volume 11, Issue 17 titled CD44+/EPCAM+ cells detect a subpopulation of ALDHhigh cells in human non-small cell lung cancer: A chance for targeting cancer stem cells?

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access, biweekly journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing OncoTarget.

From January 1, 2021 Oncotarget is a biweekly journal that is published on Tuesday.

Request Conference Sponsorship

Oncotarget Videos with Outstanding Authors

Interview with Dr. Beatrice Aramini from The University of Modena and Reggio Emilia talk about their Publication in the Open-access Bio-medical Journal Oncotarget

Correspondence to - Beatrice Aramini, email: beatrice.aramini@unimore.it

Keywords: immunophenotype, cancer stem cells, cancer stem-like cells, non-small cell lung cancer (NSCLC), target therapy

Subscribe to TOC Alerts

Oncotarget Videos with Outstanding Authors

Interview with Dr. Beatrice Aramini from The University of Modena and Reggio Emilia talk about their Publication in the Open-access Bio-medical Journal Oncotarget